Yeganeh Reuven

Director, 10% OwnerBiomX Inc. (PHGE) · full profile →Form 4 · filed Mar 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.4M
Net Open-Market Flow
-$3.4M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Sell(S)370K$5.00$1.9M0
Mar 13, 2026Conversion(C)370K$2.00$740K370K
Mar 12, 2026Sell(S)300K$5.00$1.5M0
Mar 11, 2026Conversion(C)300K$2.00$600K30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2026Conversion(C)740$02K
Mar 12, 2026Conversion(C)600$03K

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-027698) within minutes of acceptance. Every field above traces to the original document. Verify it directly: